The burden of kidney disease: Improving global outcomes
Garabed Eknoyan(Baylor College of Medicine), Haiyan Wang(Baylor College of Medicine), Adeera Levin(Providence Health Care), Alison M. MacLeod(University of Aberdeen), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Francesco Locatelli, Raymond Vanholder(Baylor College of Medicine), Nathan W. Levin(Renal Research Institute), Rowan G. Walker(Baylor College of Medicine), Norbert Lameire, Rashad S. Barsoum(Baylor College of Medicine)
Cited by 521
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k